Amgen (AMGN) Non-Current Deferred Tax Liability (2013 - 2026)

Amgen has reported Non-Current Deferred Tax Liability for 13 years, with the latest figure at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 10.99% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 10.99% YoY), and the FY2025 full-year result was $1.4 billion, down 15.47% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $2.4 billion in Q4 2023, with the low at $11.0 million in Q4 2022.
• Average Non-Current Deferred Tax Liability over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2025.
• Year-over-year, Non-Current Deferred Tax Liability soared 21300.0% in 2023 and sank 31.35% in 2024.
• Tracing AMGN's Non-Current Deferred Tax Liability over 5 years: stood at $11.0 million in 2022, then soared by 21300.0% to $2.4 billion in 2023, then slumped by 31.35% to $1.6 billion in 2024, then declined by 15.47% to $1.4 billion in 2025, then fell by 1.61% to $1.3 billion in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.

Peer Comparison